shortagewatch

Home / Blood / Erythropoietin

ATC B03XA01 · Antianemic Preparations

Erythropoietin shortage

As of 31 Oct 2026, Erythropoietin has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 41 products.

Countries4/5
Products41packs or presentations
Short since4 Jun 20242.4 years ago
Earliest return13 Nov 2026company estimate
No return date20products
Main reasonIncreased demand
Germany2 packs shortItaly33 packs shortSpain3 packs shortAustriaNo reported shortageBelgium3 packs short

Timeline

GermanyItalySpainBelgium
20252026Retacrit 2 000 I.E./0,6 ml Injektionslösung Retacrit 2 000 I.E./0,6 ml Injektionslösung in FertigspritzeRetacrit 10 000 I.E./1 ml Injektionslösung iRetacrit 10 000 I.E./1 ml Injektionslösung in FertigspritzeEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXEPREXBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITNEORECORMONNEORECORMONNEORECORMONNEORECORMONNEORECORMONNEORECORMONBINOCRITBINOCRITNEORECORMONNEORECORMONNEORECORMONNEORECORMONBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITBINOCRITRETACRITRETACRITBINOCRITBINOCRITRETACRITRETACRITRETACRITRETACRITRETACRITRETACRITRETACRITRETACRITtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DERetacrit 2 000 I.E./0,6 ml Injektionslösung in FertigspritzePfizer Europe MA EEIG6 Oct 202630 Nov 2026Increased demand
Erhöhte Nachfrage
DERetacrit 10 000 I.E./1 ml Injektionslösung in FertigspritzePfizer Europe MA EEIG27 Oct 202613 Nov 2026Increased demand
Erhöhte Nachfrage
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITEPREXJANSSEN CILAG S.P.A.4 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITBINOCRITSANDOZ GMBH10 Jun 2024not givenIncreased demand
Elevata richiesta
ITBINOCRITSANDOZ GMBH10 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITBINOCRITSANDOZ GMBH10 Jun 2024not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITNEORECORMONROCHE REGISTRATION GMBH7 Jul 202530 Jun 2027Manufacturing problem
Problemi produttivi
ITNEORECORMONROCHE REGISTRATION GMBH21 Jul 202530 Jun 2027Manufacturing problem
Problemi produttivi
ITNEORECORMONROCHE REGISTRATION GMBH18 Aug 202530 Jun 2027Manufacturing problem
Problemi produttivi
ITBINOCRITSANDOZ GMBH2 Sep 2025not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITNEORECORMONROCHE REGISTRATION GMBH8 Sep 202530 Jun 2027Manufacturing problem
Problemi produttivi
ITNEORECORMONROCHE REGISTRATION GMBH29 Sep 202530 Jun 2027Increased demand
Elevata richiesta/problemi produttivi
ITBINOCRITSANDOZ GMBH15 Jan 2026not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITBINOCRITSANDOZ GMBH24 Mar 2026not givenIncreased demand
Elevata richiesta
ITBINOCRITSANDOZ GMBH11 May 2026not givenManufacturing problem
Problemi produttivi
ITBINOCRITSANDOZ GMBH12 May 2026not givenManufacturing problem
Problemi produttivi
ITBINOCRITSANDOZ GMBH12 May 2026not givenManufacturing problem
Problemi produttivi
ITBINOCRITSANDOZ GMBH12 May 2026not givenManufacturing problem
Problemi produttivi
ITRETACRITPFIZER EUROPE MA EEIG22 May 202628 Feb 2027Increased demand
Elevata richiesta: forniture discontinue
ITBINOCRITSANDOZ GMBH15 Jun 2026not givenManufacturing problem
Problemi produttivi
ITRETACRITPFIZER EUROPE MA EEIG6 Jul 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITRETACRITPFIZER EUROPE MA EEIG13 Jul 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITRETACRITPFIZER EUROPE MA EEIG20 Jul 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITRETACRITPFIZER EUROPE MA EEIG6 Aug 202631 Dec 2026Increased demand
Elevata richiesta
ITRETACRITPFIZER EUROPE MA EEIG6 Aug 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITRETACRITPFIZER EUROPE MA EEIG22 Aug 202628 Feb 2027Increased demand
Elevata richiesta: forniture discontinue
ITRETACRITPFIZER EUROPE MA EEIG26 Aug 202631 Dec 2026Increased demand
Elevata richiesta
ITEPORATIORATIOPHARM GMBH5 Oct 2026not givenManufacturing problem
Problemi produttivi (carenza relativa solo al canale ospedaliero)
ITEPORATIO announcedRATIOPHARM GMBH7 Dec 2026not givenManufacturing problem
Problemi produttivi (carenza relativa solo al canale ospedaliero)
ESBINOCRIT, 6000 UI/0,6 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,6 ml con protector de seguridad para la agujaSandoz Gmbh27 Oct 202630 Dec 2026Not stated
ESBINOCRIT, 3000 UI/0,3 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,3 ml con protector de seguridad para la agujaSandoz Gmbh29 Oct 20269 Dec 2026Not stated
ESBINOCRIT, 4000 UI/0,4 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,4 ml con protector de seguridad para la agujaSandoz Gmbh29 Oct 202629 Nov 2026Not stated
BENeoRecormon 10 000 IU (Abacus Medicine) inj. sol. s.c./i.v. pre-filled syr. 6 x 0.6 mlRoche Registration10 Oct 202531 Dec 2026Other
Other reason
BENeoRecormon 5 000 IU (Abacus Medicine) inj. sol. s.c./i.v. pre-filled syr. 6 x 0.3 mlRoche Registration10 Oct 202531 Dec 2026Other
Other reason
BEBinocrit 10 000 IU/1 ml inj. sol. i.v./s.c. pre-filled syr. 6 x 1 mlSandoz4 Oct 202618 Nov 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.